Wealth Trust Asset Management, LLC Bristol Myers Squibb CO Transaction History

Wealth Trust Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$63.71 - $70.74 $231,394 - $256,927	-3,632 Reduced 21.53%	13,239 $846,000
Q1 2023 Apr 28, 2023	SELL	$65.71 - $74.53 $42,908 - $48,668	-653 Reduced 3.73%	16,871 $1.17 Million
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $143,054 - $169,397	-2,089 Reduced 10.65%	17,524 $1.26 Million
Q3 2022 Nov 03, 2022	SELL	$0.13 - $76.84 $1,834 - $1.08 Million	-14,113 Reduced 41.85%	19,613 $1.39 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $273,850 - $301,604	-3,771 Reduced 10.06%	33,726 $2.6 Million
Q1 2022 May 27, 2022	SELL	$61.48 - $73.72 $44,634 - $53,520	-726 Reduced 1.9%	37,497 $2.74 Million
Q4 2021 May 27, 2022	BUY	$53.63 - $62.52 $61,996 - $72,273	1,156 Added 3.12%	38,223 $2.38 Million
Q3 2021 Oct 27, 2021	BUY	$59.17 - $69.31 $9,644 - $11,297	163 Added 0.44%	37,067 $2.19 Million
Q2 2021 Jul 09, 2021	BUY	$61.91 - $67.42 $2.28 Million - $2.49 Million	36,904 New	36,904 $2.47 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wealth Trust Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Trust Asset Management, LLC with notifications on news.